SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$313.2

Market cap

$119.23B

P/E Ratio

33.11

Dividend/share

$3.52

EPS

$9.46

Enterprise value

$130.89B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 85

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and ...

Highlights
SYK's P/E is 18% below its 5-year quarterly average of 40.9 and 4% below its last 4 quarters average of 35.1
SYK's quick ratio is up by 14% YoY
SYK's net income is up by 23% year-on-year but it is down by 2.8% since the previous quarter
Stryker's EPS has increased by 23% YoY but it has decreased by 2.9% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.stryker.com
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK

SYK stock price

How has the Stryker stock price performed over time
Intraday
-1.75%
1 week
-6.53%
1 month
10.83%
1 year
-14.74%
YTD
-10.89%
QTD
13.73%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$26.3B
Gross profit
$17.18B
Operating income
$5.43B
Net income
$3.62B
Gross margin
65.3%
Net margin
13.8%
The operating income has grown by 48% year-on-year
Stryker's operating margin has increased by 38% YoY but it has decreased by 3.3% QoQ
SYK's net income is up by 23% year-on-year but it is down by 2.8% since the previous quarter
SYK's net margin is up by 14% YoY but it is down by 4.2% from the previous quarter

Price vs fundamentals

How does SYK's price correlate with its fundamentals

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
SYK P/E details
P/E
33.11
P/B
5.12
P/S
4.55
EV/EBIT
21.27
EV/EBITDA
19.7
EV/Sales
4.98
Stryker's EPS has increased by 23% YoY but it has decreased by 2.9% from the previous quarter
SYK's P/E is 18% below its 5-year quarterly average of 40.9 and 4% below its last 4 quarters average of 35.1
SYK's P/B is 15% below its 5-year quarterly average of 6.1
SYK's equity is up by 8% year-on-year but it is down by 2.2% since the previous quarter
The stock's price to sales (P/S) is 16% less than its 5-year quarterly average of 5.5 and 3.5% less than its last 4 quarters average of 4.8
The company's revenue rose by 8% YoY

Efficiency

How efficient is Stryker business performance
Stryker's ROIC has increased by 46% YoY
Stryker's ROS has increased by 36% YoY but it has decreased by 2.5% from the previous quarter
The ROA has grown by 18% YoY but it has contracted by 2.5% from the previous quarter
The ROE rose by 12% YoY but it fell by 4.9% QoQ

Dividends

What is SYK's dividend history
Dividend details
DPS
$3.52
Dividend yield
1.12%
Payout ratio
37.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Stryker financials performed over time
The total assets is 99% greater than the total liabilities
The current ratio has grown by 18% year-on-year
SYK's quick ratio is up by 14% YoY
SYK's debt is 36% less than its equity
The debt to equity has contracted by 16% YoY but it has grown by 3.2% from the previous quarter
SYK's debt is down by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.